Results 151 to 160 of about 11,372 (280)

Treatment options of invasive fungal infections in adults. [PDF]

, 2006
A panel of infectious disease specialists, clinical microbiologists and hospital epidemiologists of the five Swiss university hospitals reviewed the current literature on the treatment of invasive fungal infections in adults and formulated guidelines for
Bille, J, Calandra, T, Eggimann, P, Flückiger, U, Fungal, Infection Network of Switzerland (FUNGINOS), Garbino, J, Glauser, M, Imhof, A, Marchetti, O, Pittet, D, Ruef, C, Täuber, M, Zimmerli, S   +12 more
core  

Drug susceptibility profiles of Candida species isolated from the oral mucosa of HIV-positive West African patients using the TREK Sensititre system [PDF]

, 2013
Poster presented at ASM2013, 113th General Meeting, American Society of Microbiology, 18-21 May, Denver, ColoradoBACKGROUND: Candida infections are a common cause of death in immunocompromised patients.
Abrantes, Pedro Miguel dos Santos, Africa, Charlene W.J., Awasom, Charles, Ayuk, L., McArthur, Carole P.   +4 more
core  

Evaluation of the Disk Diffusion Method Compared to the Microdilution Method in Susceptibility Testing of Anidulafungin against Filamentous Fungi [PDF]

, 2008
Carmelo Massimo Maida, Maria Eleonora Milici, Laura Trovato, Salvatore Massimo Oliveri, Emanuele Amodio, Elisabetta Spreghini, Giorgio Scalise, Francesco Barchiesi   +7 more
openalex   +1 more source

Clin Microbiol Newsl [PDF]

There are several new hot topics in antifungals and antifungal susceptibility testing. In this review, four topics of general interest to the clinical microbiology community are discussed.

core  

Cost-effectiveness of three echinocandins and fluconazole in the treatment of candidemia and/or invasive candidiasis in nonneutropenic adult patients

ClinicoEconomics and Outcomes Research, 2015
S Grau,1 JC Pozo,2 E Romá,2 M Salavert,3 JA Barrueta,4 C Peral,4 I Rodriguez,5 D Rubio-Rodríguez,6 C Rubio-Terrés6 1Hospital del Mar (IMIM), Barcelona, 2Hospital Universitario Reina Sofía, Córdoba, 3Hospital ...
Grau S, Pozo JC, Romá E, Salavert M, Barrueta JA, Peral C, Rodriguez I, Rubio-Rodríguez D, Rubio-Terrés C   +8 more
doaj  

Bronchopulmonary Disposition of Intravenous Voriconazole and Anidulafungin Given in Combination to Healthy Adults [PDF]

, 2009
Jared L. Crandon, Mary Anné Banevicius, Annie Fang, Penelope Crownover, R. Fredrick Knauft, J. Samuel Pope, John Russomanno, Eric Shore, David P. Nicolau, Joseph L. Kuti   +9 more
openalex   +1 more source

Differential in vitro activity of anidulafungin, caspofungin and micafungin against Candida parapsilosis isolates recovered from a burn unit [PDF]

, 2009
Mahmoud A. Ghannoum, Alexander Wu Chen, Mudathiru A. Buhari, J. Chandra, Pranab K. Mukherjee, Dwayne Baxa, Alicia Golembieski, José A. Vázquez   +7 more
openalex   +1 more source

Combination Therapy of Advanced Invasive Pulmonary Aspergillosis in Transiently Neutropenic Rats Using Human Pharmacokinetic Equivalent Doses of Voriconazole and Anidulafungin [PDF]

, 2009
Wendy W. J. van de Sande, Ron A. A. Mathôt, Marian T. ten Kate, Wim van Vianen, Mehri Tavakol, Bart Rijnders, Irma A. J. M. Bakker‐Woudenberg   +6 more
openalex   +1 more source

FKS2 Mutations Associated with Decreased Echinocandin Susceptibility of Candida glabrata following Anidulafungin Therapy [PDF]

, 2010
Sofia Costa‐de‐Oliveira, Isabel M. Miranda, Raquel M. Silva, Ana P. Silva, Rita Rocha, António Amorim, Acácio G. Rodrigues, Cidália Pina‐Vaz   +7 more
openalex   +1 more source

Cost-effectiveness analysis of anidulafungin versus fluconazole for the treatment of invasive candidiasis [PDF]

, 2011
Chin Fen Neoh, Danny Liew, Monica A. Slavin, D. Marriott, S. C.- A. Chen, Orla Morrissey, K. Stewart, David C. M. Kong   +7 more
openalex   +1 more source